InsiderTrades

Form 4 for LSTA LISATA THERAPEUTICS, INC.

Accepted 2022-01-12 00:00:00 ET · period of report 2022-01-10 · accession 0001334549-22-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-01-12 2022-01-10+ LSTA Mazzo David J CEO, Dir F - Tax $0.9086 -73.2K 644.1K -10% -$66.5K
D 2022-01-12 2022-01-10 LSTA Mazzo David J CEO, Dir A - Grant $0.00 +401.0K 717.3K +127% $0
D 2022-01-12 2022-01-10 LSTA Mazzo David J CEO, Dir A - Grant $0.00 +200.0K 200.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-01-10 F D 56,410 $0.92 660,887 D — — (F3) Shares withheld as payment of a tax liability on vesting of restricted stock. (F2) Includes 424,750 unvested restricted stock.
2 Common Common Stock 2022-01-11 F D 16,740 $0.87 644,147 D — — (F3) Shares withheld as payment of a tax liability on vesting of restricted stock. (F4) Includes 395,000 unvested restricted stock.
3 Common Common Stock 2022-01-10 A A 401,000 $0.00 717,297 D — — (F1) Represents 401,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date. (F2) Includes 424,750 unvested restricted stock.
4 Derivative Stock Option (Right to Buy) 2022-01-10 A A 200,000 $0.00 200,000 D $0.92 · 2022-01-10 to 2032-01-10 200,000 Common Stock (F5) One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.